Ambrx Biopharma Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 53.68, this represents a new company high. This is a clear indication for improving liquidity at Ambrx Biopharma Inc 's clients. Average receivable collection period, for the Ambrx Biopharma Inc in Sep 30 2023 quarter, has decreased to 7 days, compared to 18 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 37 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 283 to 348.

What is Receivable Turnover Ratio?
What is Ambrx Biopharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMAM Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	-91.68 %	-93.46 %	-95 %	-69.65 %	18.32 %
Y / Y Revenue Change	-96.68 %	-13.55 %	-98.51 %	-0.71 %	-
Receivable Turnover Ratio (TTM)	53.68	20.45	13.14	11.03	9.23
AMAM's Total Ranking	# 348	# 283	# 0	# 0	#
Accounts Receivable average collection period days	7	18	28	33	40
Seq. Receivable Change	50.62 %	30.65 %	-83.51 %	-74.35 %	18.32 %
Seq. Revenue Change	-95.28 %	4579.17 %	-99.68 %	363.49 %	22.94 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 5
Healthcare Sector	# 38
Overall Market	# 348

Receivable Turnover Ratio Statistics
High	Average	Low
53.68	20.86	6.02
(Sep 30 2023)		(Dec 31 2021)

AMAM Company Profile • Back to AMAM Efficiency Comparisons • Compare AMAM Receivables Turnover Ratio to its Competitors

Financial Statements
Ambrx Biopharma Inc 's Accounts Receivable	$ 0 Millions	Visit AMAM's Balance sheet
Ambrx Biopharma Inc 's Sales TTM	$ 9 Millions	Visit AMAM's Income Statement
Sources of AMAM's Revenues		Visit AMAM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMAM's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMAM's Growth Rates	AMAM's Roa	AMAM's Inventory Turnover Ratio	AMAM's Dividend Comparisons
AMAM's Profitability Ratios	AMAM's Roi	AMAM's Asset Turnover Ratio	AMAM's Dividend Growth
AMAM's Valuation Ratios	AMAM's Roe	AMAM's Financial Strength Ratios	AMAM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Zeo Scientifix Inc	170.30	$ 4.558 Millions	$ 0.027 Millions
Agape Atp Corporation	164.02	$ 1.427 Millions	$ 0.009 Millions
Earth Science Tech Inc	139.75	$ 2.196 Millions	$ 0.016 Millions
Nurix Therapeutics Inc	137.22	$ 68.611 Millions	$ 0.500 Millions
Healthlynked Corp	118.06	$ 5.946 Millions	$ 0.050 Millions
Relay Therapeutics Inc	117.14	$ 25.800 Millions	$ 0.220 Millions
Renalytix Plc	115.56	$ 5.778 Millions	$ 0.050 Millions
Electromedical Technologies Inc	113.10	$ 1.420 Millions	$ 0.013 Millions
Fonar Corporation	104.93	$ 101.292 Millions	$ 0.965 Millions
Prothena Corporation Public Limited Company	99.23	$ 140.977 Millions	$ 1.421 Millions
Orthofix Medical Inc	98.14	$ 667.747 Millions	$ 6.804 Millions
Lifevantage Corp	86.64	$ 212.421 Millions	$ 2.452 Millions
Logicmark Inc	80.11	$ 9.650 Millions	$ 0.120 Millions
Alpine Immune Sciences Inc	78.82	$ 30.799 Millions	$ 0.391 Millions
Tango Therapeutics Inc	75.01	$ 37.507 Millions	$ 0.500 Millions
Pavmed Inc	63.57	$ 1.923 Millions	$ 0.030 Millions
Scynexis Inc	62.10	$ 135.869 Millions	$ 2.188 Millions
Clearday Inc	61.82	$ 7.543 Millions	$ 0.122 Millions
Agenus Inc	61.81	$ 100.897 Millions	$ 1.632 Millions
Lucid Diagnostics Inc	60.00	$ 1.500 Millions	$ 0.025 Millions
Brookdale Senior Living Inc	57.81	$ 2,949.838 Millions	$ 51.031 Millions
Embecta Corp	56.63	$ 1,119.900 Millions	$ 19.775 Millions
Aridis Pharmaceuticals Inc	55.31	$ 22.359 Millions	$ 0.404 Millions
Sangamo Therapeutics Inc	55.30	$ 201.420 Millions	$ 3.642 Millions
Ambrx Biopharma Inc	53.68	$ 8.602 Millions	$ 0.160 Millions
Vireo Growth Inc.	50.94	$ 83.003 Millions	$ 1.629 Millions
Rosecliff Acquisition Corp I	49.74	$ 16.315 Millions	$ 0.328 Millions
Wave Life Sciences Ltd	48.85	$ 85.488 Millions	$ 1.750 Millions
Janux Therapeutics Inc	45.16	$ 8.467 Millions	$ 0.188 Millions
Ngm Biopharmaceuticals Inc	45.02	$ 22.433 Millions	$ 0.498 Millions

Date modified: 2026-10-07T07:49:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.